2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Hyperplasia in 1 studies
2,2-bis(4-glycidyloxyphenyl)propane: structure
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, RJ | 1 |
| Wu, MQ | 1 |
| Li, ZJ | 1 |
| Zhang, Y | 1 |
| Liu, KY | 1 |
1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Hyperplasia
| Article | Year |
|---|---|
Hematopoietic recovery following chemotherapy is improved by BADGE-induced inhibition of adipogenesis.
Topics: Adipocytes; Adipogenesis; Animals; Antineoplastic Agents; Benzhydryl Compounds; Bone Marrow; Cell Di | 2013 |